FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Medtronic Spinal Cord Stimulator OKd

FDA approves a Medtronic PMA for the Inceptiv closed-loop rechargeable spinal cord stimulator for treating chronic pain.

latest-news-card-1
Biologics

Marks Outlines CBER 2024 Top Priorities

CBER director Peter Marks outlines the top priorities at the Center this year that include updating the Centers tissue guidance to reduce the risk of ...

latest-news-card-1
Federal Register

Lab Values for Cancer Trial Eligibility Guide

Federal Register notice: FDA makes available a draft guidance entitled Cancer Clinical Trial Eligibility Criteria: Laboratory Values.

latest-news-card-1
Federal Register

Trial Performance Status Eligibility Criteria Guide

Federal Register notice: FDA makes available a draft guidance entitled Cancer Clinical Trial Eligibility Criteria: Performance Status.

latest-news-card-1
Federal Register

Guide on Washout Period Eligibility Criteria

Federal Register notice: FDA makes available a draft guidance entitled Cancer Clinical Trial Eligibility Criteria: Washout Periods and Concomitant Med...

latest-news-card-1
Medical Devices

Elekta Recalls Disposable Biopsy Needles

Elekta Instrument recalls its Disposable Biopsy Needles from one batch (837838839) because they possibly contain some microscopic stainless steel debr...

latest-news-card-1
Human Drugs

Pfizer Hemophilia B Gene Therapy Approved

FDA approves Pfizers Beqvez (fidanacogene elaparvovec-dzkt), a gene therapy for treating adults with moderate to severe hemophilia B.

latest-news-card-1
Medical Devices

InfuTronix Recalls Malfunctioning Infusion Pumps

InfuTronix recalls its Nimbus infusion pump systems due to multiple potential failure modes that may include battery failure, upstream blockage (occlu...

latest-news-card-1
Medical Devices

Expanse ICE Clot Aspiration Device Cleared

FDA clears an Expanse ICE 510(k) for the ICE Aspiration System for use in peripheral thrombectomy procedures.

latest-news-card-1
Human Drugs

FDA Fast Track for Compass Biliary Tract Cancer Drug

FDA grants fast track designation to Compass CTX-009 that is in a Phase 2 study with paclitaxel to treat some biliary tract tumors.